List of works - Eric S Yvon

Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

scientific article

An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies

scientific article published on June 2010

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma

scientific article published on 7 October 2011

Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia ⬇️

scientific article published on July 12, 2011

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

scientific article published on 16 March 2015

Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy

scientific article published on September 2008

GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade

scientific article published on 29 March 2016

Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.

scientific article published on 15 February 2005

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

scientific article published on 25 October 2005

Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells

scientific article published on 8 September 2009

Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma

scientific article published on 24 October 2002

Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells

scientific article published on 3 July 2003

Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma

scientific article

Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression

scientific article published on 18 November 2009

Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses

scientific article published on 22 May 2003

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution

article by Joshua N Kellner et al published 2 November 2018 in Oncotarget

Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease

scientific article

Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.

scientific article published on 26 February 2014

List of works by Eric S Yvon

Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma

Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia ⬇️

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy

GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade

Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells

Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma

Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells

Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma

Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression

Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution

Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease

Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.